Mark Smith
Director/Board Member chez Freya Biosciences ApS
Fortune : 164 928 $ au 31/03/2024
Profil
Mark Smith was the founder of Finch Therapeutics Group, Inc. (founded in 2017) and The Microbiome Health Research Institute, Inc. (founded in 2012), where he held the titles of Chief Executive Officer & Director and President, Director & Research Director, respectively.
He is currently a Director at Freya Biosciences ApS.
Dr. Smith holds a doctorate degree from Massachusetts Institute of Technology and an undergraduate degree from Princeton University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/04/2023 | 63 434 ( 3,95% ) | 164 928 $ | 31/03/2024 |
Postes actifs de Mark Smith
| Sociétés | Poste | Début |
|---|---|---|
Freya Biosciences ApS
 Freya Biosciences ApS Miscellaneous Commercial ServicesCommercial Services Freya Biosciences ApS is a clinical-stage biotech company based in Copenhagen, Denmark, that is dedicated to advancing women's reproductive health. The Danish company focuses on reproductive microbial immunotherapy interventions to improve fertility outcomes and empower women with innovative solutions. Freya Biosciences aims to address immune drivers underlying a range of reproductive health conditions to create a future where everyone is empowered with optimal reproductive health. The company was founded by Johan van Hylckama Vlieg, Colleen Acosta, Randi Rich, and Ulrich Binné, and Colleen Acosta has been the CEO since incorporation. | Director/Board Member | - |
Anciens postes connus de Mark Smith
| Sociétés | Poste | Fin |
|---|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Founder | 15/05/2023 |
The Microbiome Health Research Institute, Inc.
 The Microbiome Health Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Microbiome Health Research Institute, Inc. operates a public stool bank. It specializes in stool preparations to clinicians for fecal microbiota transplantation and to catalyse research into the human microbiome. The company was founded by James Burgess and Mark Smith in 2012 and is headquartered in Somerville, MA. | Founder | 01/07/2016 |
Formation de Mark Smith
| Massachusetts Institute of Technology | Doctorate Degree |
| Princeton University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Health Services |
| Entreprise privées | 2 |
|---|---|
The Microbiome Health Research Institute, Inc.
The Microbiome Health Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Microbiome Health Research Institute, Inc. operates a public stool bank. It specializes in stool preparations to clinicians for fecal microbiota transplantation and to catalyse research into the human microbiome. The company was founded by James Burgess and Mark Smith in 2012 and is headquartered in Somerville, MA. | Commercial Services |
Freya Biosciences ApS
Freya Biosciences ApS Miscellaneous Commercial ServicesCommercial Services Freya Biosciences ApS is a clinical-stage biotech company based in Copenhagen, Denmark, that is dedicated to advancing women's reproductive health. The Danish company focuses on reproductive microbial immunotherapy interventions to improve fertility outcomes and empower women with innovative solutions. Freya Biosciences aims to address immune drivers underlying a range of reproductive health conditions to create a future where everyone is empowered with optimal reproductive health. The company was founded by Johan van Hylckama Vlieg, Colleen Acosta, Randi Rich, and Ulrich Binné, and Colleen Acosta has been the CEO since incorporation. | Commercial Services |
